Evolution Summit March 2021
03 March 2021 - 05 March 2021
Evolution March: The Evolution Online Summit is an invitation-only, premium Summit bringing leading clinical trial executives and innovative suppliers and solution providers together. The Summit’s content is aligned with key clinical trial challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers.
Online Summit
http://www.os.evolutionsummit.com
The Reality of Artificial intelligence in Drug Discovery
04 March 2021 - 04 March 2021
Artificial Intelligence is constantly in the news, with applications from self-driving cars, healthcare, share-trading, and law. There are also many applications in drug discovery and development, and the promise of the field has led to the formation of many new AI companies, formation of AI groups at large pharma and significant financial investment in the field. Automated drug design, drug repurposing and retrosynthesis are just a few of the specific application areas of AI. But how does the reality match the hype. The meeting brings together recognised experts to provide a realistic view and discuss the likely future of AI in Drug Discovery.
Virtual Conference
https://www.smr.org.uk/Meetings/20210304/
SMi’s 2nd Annual AI in Drug Discovery
15 March 2021 - 16 March 2021
Exploring the latest Innovations in Machine Learning for Enhancing Discovery Pipelines
SMi is proud to present its 2nd Annual AI in Drug Discovery Conference, taking place on the 15-16 March 2021.
With the global Artificial Intelligence (AI) in Drug Discovery Market size expected to exceed $3,900 million by 2027, the conference agenda will encompass key drivers leading the way into a shorter, cheaper, and more successful R&D era. The conference will be a particular focus on case studies from leading pharma and biotech, as well as a close-up view on the paradigm shift from undruggable targets to ‘challenging to drug’.
Furthermore the event will focus on 4 key themes: machine learning and automation for improved drug discovery pipelines; effective prediction of compound properties; data robustness and curation; innovative use of AI for rare and undruggable diseases, and will highlight key case studies across these themes, uncovering key developments in pharma of data optimization and to aid therapeutic discovery. Real-world examples of AI in structure-based drug design and patient relevant data will be explored in eye-opening detail
Event Hashtag: #SMiAIDrugDis
Virtual Conference
http://www.ai-indrugdiscovery.com/drugdiscoverytodayWB
Venture Summit Virtual Connect West
16 March 2021 - 18 March 2021
LINK HERE TO RECEIVE A 20% DISCOUNT OFF THE EARLY BIRD RATE WITH PROMO CODE DDTVIP
Join over 120 leading VCs, Corp VCs, Angel Investors and over 100 Top Innovators online at #VSVC Venture Summit Virtual Connect West being held on March 16th – 18th 2020. Dedicated Lifesciences/Healthcare Track, One-on-One (zoom) investor meetings, 2 days of content including timely panel discussions, workshops and an inspiring keynotes. Register now to confirm your spot: https://bit.ly/3olhNB9 & get a deep discount, currently an extra 20% off the Early Bird Rates with PromoCode: DDTVIP.
Whether you are an investor seeking access to new early stage deals, or a CEO or Founder of a new venture looking for funding, visibility and growth, Venture Summit Virtual Connect is one event you won’t want to miss.
#VSVC #VIRTUALEVENTS #STAYHOMESTAYSAFE #VENTURENURTURING #VCINCLUSION #VCDIVERSITY
Virtual Summit
https://bit.ly/3olhNB9
Parallel Trade 2021 – Virtual conference: online access only
22 March 2021 - 23 March 2021
SMi present’s its 15th annual Parallel Trade virtual conference, taking place virtually on the 22nd and the 23rd March 2021. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade.
The 2021 event will be more significant than ever before due to the transition period after Brexit coming to an end this year. As such, the UK will no longer be part of the EU free market. This will mean increased medicines prices, reduced access to some specialist drugs and greater risk of supply chain shortages. In a post-Brexit environment, exhaustion of rights will cease to apply to the UK, making import and export a costly business and in a worst-case scenario could effectively kill parallel distribution.
This conference will bring together industry experts to discuss the challenges and drivers of the industry, including the EU regulatory landscape and the impact of the FMD (Falsified Medicines Directive). The conference will also provide global insights on Parallel trade and will reflect on key takeaways for other member states.
Virtual Conference
http://www.parallel-trade.com/DDTwl